OpenVSafe by OpenVAERS
Search V-safe

RP5-13875-32914

2 vaccinations 1 coded response 16 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
21-25
ZIP prefix
186 / PA
Registered
2022-01-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-01-18
    Registered in v-safe
  2. 2022-01-18
    Dose 1 — Pfizer-BioNTech
  3. 2022-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  4. 2022-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2022-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2022-02-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2022-02-08
    Dose 2 — Pfizer-BioNTech
  8. 2022-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2022-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2022-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2022-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2022-02-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2022-03-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-03-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-03-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-03-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-05-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-08-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2023-02-08
    Survey response — 12 months, dose 2
    MedDRA: Attention deficit hyperactivity disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  20. 2023-02-08
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  21. 2023-02-09

Vaccinations

DoseDateManufacturerCo-administered
12022-01-18Pfizer-BioNTech No
22022-02-08Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAttention deficit hyperactivity disorder · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release